Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2014 | Research article

The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study

Authors: Sun-Young Kim, Sung-Pa Park

Published in: The Journal of Headache and Pain | Issue 1/2014

Abstract

Background

Headache chronicity has been known to elicit deleterious effects on quality of life (QOL). We evaluated the contribution of headache chronicity to QOL in relation to clinical, psychiatric, and psychosocial variables in patients with migraine.

Methods

Subjects were recruited from a headache clinic and completed self-report questionnaires including the Migraine Disability Assessment (MIDAS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Migraine-Specific Quality of Life (MSQoL). We obtained predictors of MSQoL by multiple regression analyses. A path analysis model was constructed to analyze interrelationships between the variables.

Results

Among 251 eligible patients, 183 (72.9%) had episodic migraine (EM) and 68 (27.1%) had chronic migraine (CM). Patients with CM had more serious clinical, psychiatric, and poor QOL than did patients with EM. The strongest predictor of the MSQoL score in all patients with migraine was the BDI score (β = -0.373, p < 0.001), followed by the MIDAS score (β = -0.223, p < 0.001), female gender (β = -0.192, p < 0.001), attack duration (β = -0.159, p = 0.001), and headache chronicity (β = -0.130, p = 0.012). Headache chronicity had a direct effect on the MSQoL score and exerted an indirect effect on the MSQoL score through the MIDAS and the BDI scores.

Conclusions

Chronic migraine appears to impair QOL directly as well as indirectly by provoking disability and depression.

Available only for authorised users

Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Wikler D, Lopez AD: GBD 2010: design, definitions, and metrics. Lancet 2012, 380: 2063–2066. doi:10.1016/S0140–6736(12)61899–6 10.1016/S0140-6736(12)61899-6CrossRefPubMed

Leonardi M, Raggi A: Burden of migraine: international perspectives. Neurol Sci 2013, 34(Suppl 1):S117-S118. doi:10.1007/s10072–013–1387–8CrossRefPubMed

Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, Group AA: Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68: 343–349. doi:10.1212/01.wnl.0000252808.97649.21 10.1212/01.wnl.0000252808.97649.21CrossRefPubMed

Lucas C, Geraud G, Valade D, Chautard MH, Lanteri-Minet M: Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache 2006, 46: 715–725. doi:10.1111/j.1526–4610.2006.00430.x 10.1111/j.1526-4610.2006.00430.xCrossRefPubMed

Roncolato M, Fabbri L, Recchia G, Cavazzuti L, Visona G, Brignoli O, Medea G: An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPs. Eur Neurol 2000, 43: 102–106. 10.1159/000008143CrossRefPubMed

Kim BK, Chung YK, Kim JM, Lee KS, Chu MK: Prevalence, clinical characteristics and disability of migraine and probable migraine: a nationwide population-based survey in Korea. Cephalalgia 2013, 33: 1106–1116. doi:10.1177/0333102413484990 10.1177/0333102413484990CrossRefPubMed

Edeh J, Toone B: Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice. Br J Psychiatry 1987, 151: 95–101. 10.1192/bjp.151.1.95CrossRefPubMed

Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.

Pascual J, Colas R, Castillo J: Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001, 5: 529–536. 10.1007/s11916-001-0070-6CrossRefPubMed

10.

Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB: Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med 2010, 52: 8–14. doi:10.1097/JOM.0b013e3181c1dc56 10.1097/JOM.0b013e3181c1dc56CrossRefPubMed

11.

Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, Reed M, Lipton RB: Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2009, 49: 498–508. doi:10.1111/j.1526–4610.2009.01369.x 10.1111/j.1526-4610.2009.01369.xCrossRefPubMed

12.

Payne KA, Varon SF, Kawata AK, Yeomans K, Wilcox TK, Manack A, Buse DC, Lipton RB, Goadsby PJ, Blumenfeld AM: The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics. Cephalalgia 2011, 31: 1116–1130. doi:10.1177/0333102411410610 10.1177/0333102411410610CrossRefPubMed

13.

Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB: Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 2011, 31: 301–315. doi:10.1177/0333102410381145 10.1177/0333102410381145CrossRefPubMed

14.

Buse DC, Manack A, Serrano D, Turkel C, Lipton RB: Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010, 81: 428–432. doi:10.1136/jnnp.2009.192492 10.1136/jnnp.2009.192492CrossRefPubMed

15.

Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, Lala N, Negro A, Simmaco M, Girardi P, Martelletti P: Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci 2012, 16: 1389–1398.PubMed

16.

Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P: Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat 2010, 6: 81–91.PubMedCentralCrossRefPubMed

17.

Dahlof CG, Dimenas E: Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia 1995, 15: 31–36. 10.1046/j.1468-2982.1995.1501031.xCrossRefPubMed

18.

Dueland AN, Leira R, Cabelli ST: The impact of migraine on psychological well-being of young women and their communication with physicians about migraine: a multinational study. Curr Med Res Opin 2005, 21: 1297–1305. doi:10.1185/030079905X56394 10.1185/030079905X56394CrossRefPubMed

19.

Stuginski-Barbosa J, Dach F, Bigal M, Speciali JG: Chronic pain and depression in the quality of life of women with migraine–a controlled study. Headache 2012, 52: 400–408. doi:10.1111/j.1526–4610.2012.02095.x 10.1111/j.1526-4610.2012.02095.xCrossRefPubMed

20.

Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF: Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000, 55: 629–635. 10.1212/WNL.55.5.629CrossRefPubMed

21.

Brna P, Gordon K, Dooley J: Health-related quality of life among Canadians with migraine. J Headache Pain 2007, 8: 43–48. doi:10.1007/s10194–007–0320–4 10.1007/s10194-007-0320-4PubMedCentralCrossRefPubMed

22.

Canuet L, Ishii R, Fernandez-Concepcion O, Iwase M, Takeda M: Severity of depressive symptoms as predictor of impairment of quality of life in chronic migraine: comparison with episodic migraine. Psychiatry Clin Neurosci 2008, 62: 738–740. doi:10.1111/j.1440–1819.2008.01867.x 10.1111/j.1440-1819.2008.01867.xCrossRefPubMed

23.

Kolotylo CJ, Broome ME: Predicting disability and quality of life in a community-based sample of women with migraine headache. Pain Manag Nurs 2000, 1: 139–151. doi:10.1053/jpmn.2000.19344 10.1053/jpmn.2000.19344CrossRefPubMed

24.

Leonardi M, Raggi A, Bussone G, D'Amico D: Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 2010, 50: 1576–1586. doi:10.1111/j.1526–4610.2010.01770.x 10.1111/j.1526-4610.2010.01770.xCrossRefPubMed

25.

Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26: 742–746. doi:10.1111/j.1468–2982.2006.01172.xCrossRefPubMed

26.

Lee HS, Chung CS, Song HJ, Park HS: The Reliability and Validity of the MIDAS (Migraine Disability Assessment) Questionnaire for Korean Migraine Sufferers. J Korean Neurol Assoc 2000, 18: 287–291.

27.

Rhee MK, Lee YH, Jung HY, Choi JH, Kim SH, Kim YH, Lee SK: A standardization study of Beck Depression Inventory (II): Korean version (K-BDI): validity. Korean J Psychopathol 1995, 4: 96–104.

28.

Yook SP, Kim ZS: A clinical study on the Korean version of beck anxiety inventory; comparative study of patient and non-patient. Korean J Clin Psychol 1997, 16: 185–197.

29.

Moon HS, Chung CS, Lee HS, Park HS, Kim SW, Woo HW: The reliability and validity of the migraine-specific quality of life questionnaire for Korean migraine suffers. J Korean Neurol Assoc 2003, 21: 146–155.

30.

Wagner TH, Patrick DL, Galer BS, Berzon RA: A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache 1996, 36: 484–492. 10.1046/j.1526-4610.1996.3608484.xCrossRefPubMed

31.

Sanin LC, Mathew NT, Bellmeyer LR, Ali S: The International Headache Society (IHS) headache classification as applied to a headache clinic population. Cephalalgia 1994, 14: 443–446. 10.1046/j.1468-2982.1994.1406443.xCrossRefPubMed

32.

Wang SJ, Wang PJ, Fuh JL, Peng KP, Ng K: Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan. Cephalalgia 2013, 33: 171–181. doi:10.1177/0333102412468668 10.1177/0333102412468668CrossRefPubMed

33.

Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, Group PCMS: OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010, 50: 921–936. doi:10.1111/j.1526–4610.2010.01678.x 10.1111/j.1526-4610.2010.01678.xCrossRefPubMed

34.

Katsarava Z, Manack A, Yoon MS, Obermann M, Becker H, Dommes P, Turkel C, Lipton RB, Diener HC: Chronic migraine: classification and comparisons. Cephalalgia 2011, 31: 520–529. doi:10.1177/0333102410383590 10.1177/0333102410383590CrossRefPubMed

35.

Burt VK, Stein K: Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002, 63(Suppl 7):9–15.PubMed

36.

Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106: 81–89. 10.1016/S0304-3959(03)00293-8CrossRefPubMed

37.

Diener HC, Holle D, Dodick D: Treatment of chronic migraine. Curr Pain Headache Rep 2011, 15: 64–69. doi:10.1007/s11916–010–0159-x 10.1007/s11916-010-0159-xCrossRefPubMed

38.

Breslau N, Davis GC, Schultz LR, Peterson EL: Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache 1994, 34: 387–393. 10.1111/j.1526-4610.1994.hed3407387.xCrossRefPubMed

39.

First MB, Spitzer RL, Gibbon M, Williams JB: Structured Clinical Interview for DSM-IV® Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. Arlington, VA: American Psychiatric Pub; 2012.

40.

Peng KP, Wang SJ: Migraine diagnosis: screening items, instruments, and scales. Acta Anaesthesiol Taiwan 2012, 50: 69–73. doi:10.1016/j.aat.2012.05.002 10.1016/j.aat.2012.05.002CrossRefPubMed

41.

Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, Kosinski M: Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache 2012, 52: 409–421. doi:10.1111/j.1526–4610.2011.01997.x 10.1111/j.1526-4610.2011.01997.xCrossRefPubMed

Title: The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study
Authors: Sun-Young Kim
Sung-Pa Park
Publication date: 01-12-2014
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/1129-2377-15-68

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Central effects of acetylsalicylic acid on trigeminal-nociceptive stimuli

Pericranial tenderness in chronic tension-type headache: the Akershus population-based study of chronic headache

Recurrent headache and interpersonal violence in adolescence: the roles of psychological distress, loneliness and family cohesion: the HUNT study

The global burden of headache in children and adolescents – developing a questionnaire and methodology for a global study

The origin of nausea in migraine–A PET study

Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial